Marcie Tomblyn
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 31
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 5
- Epidemiology top 1%
- Infectious Diseases top 2%
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 6
- Oncology top 2%
-
- Chronic Lymphocytic Leukemia Research 10
-
- Acute Lymphoblastic Leukemia research 10
-
- Lymphoma Diagnosis and Treatment 10
-
- Immune Cell Function and Interaction 6
Marcie Tomblyn
51 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 1.0k
- Epidemiology 1.8k
- Infectious Diseases 901
- Transplantation 109
- Oncology 1.0k
Countries citing papers authored by Marcie Tomblyn
This map shows the geographic impact of Marcie Tomblyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcie Tomblyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcie Tomblyn more than expected).
Fields of papers citing papers by Marcie Tomblyn
This network shows the impact of papers produced by Marcie Tomblyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcie Tomblyn. The network helps show where Marcie Tomblyn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcie Tomblyn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 88 | |
| 2 | 2013 | 8 | |
| 3 | 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Hostbreakdown → | 2013 | 1081 |
| 4 | 2013 | 3 | |
| 5 | 2012 | 1 | |
| 6 | 2012 | 4 | |
| 7 | 2011 | 44 | |
| 8 | 2011 | 14 | |
| 9 | 2011 | 1 | |
| 10 | 2011 | 1 | |
| 11 | 2011 | 1 | |
| 12 | 2010 | 26 | |
| 13 | 2010 | 58 | |
| 14 | 2010 | 48 | |
| 15 | Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspectivebreakdown → | 2009 | 1149 |
| 16 | 2009 | 1 | |
| 17 | 2009 | 29 | |
| 18 | 2009 | 20 | |
| 19 | 2008 | 56 | |
| 20 | 2003 | 15 |
About Marcie Tomblyn
Marcie Tomblyn is a scholar working on Hematology, Transplantation and Genetics, having authored 51 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (31 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (9 papers), Renal Transplantation Outcomes and Treatments (6 papers), Immune Cell Function and Interaction (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (1.0k citations), Epidemiology (1.8k citations) and Infectious Diseases (901 citations). Marcie Tomblyn has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Per Ljungman, Harry Keyserling, Athos Bousvaros, Robin K. Avery, E. Graham Davies, Lillian Sung, Myron J. Levin, Lorry G. Rubin, Shireesha Dhanireddy and Insoo Kang. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.